HeberFERON, formulation based on IFNs alpha2b and gamma for the treatment of non-melanoma skin cancer
Conclusion HeberFERON is a novel, non-surgical, effective and safe option to treat advanced, high risk or recurrent non-melanoma skin cancer.
Source: Australasian Medical Journal - AMJ - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Cuba Health | General Medicine | Immunotherapy | Medical Ethics | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Study